External quality assurance scheme for Haemophilus influenzae 2009
Haemophilus influenzae is a common cause of respiratory tract infections and its surveillance is of the utmost importance. ECDC promotes the performance of External Quality Assurance (EQA) schemes, in which laboratories are sent simulated clinical specimens or bacterial isolates for testing by routine and/or reference laboratory methods. In January 2009, a collection of six strains of Haemophilus spp. and one other microorganism (Aggregatibacter aphrophilus, which could be misidentified as Haemophilus spp.) was sent to 26 participating reference laboratories in the IBD-Labnet surveillance network for quality assurance testing. The laboratories were requested to perform standard protocols for the methods usually used for: species identification, biotyping and serotyping by serological methods and/or PCR. Antimicrobial susceptibility tests and beta-lactamase testing were also requested for those laboratories that perform antimicrobial susceptibility testing of the isolates on a routine basis. This report presents the results of this exercise.
ECDC Evidence Brief: Pre-exposure prophylaxis for HIV prevention in Europe and Central Asia
28 Nov 2019 - This evidence brief summarises key issues and priorities for action in Europe and Central Asia on PrEP. It is largely based on data collected in 2018 and 2019 by the European Centre for Disease Prevention and Control (ECDC) to monitor implementation of the 2004 Dublin Declaration. The monitoring questionnaire was disseminated to the 53 countries that are part of the WHO European Region, plus Kosovo and Liechtenstein via an online survey.
HIV testing, Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report
27 Nov 2019 - This report presents the situation of HIV testing in Europe and Central Asia. It summarises data on implementation of national guidelines that shape HIV testing policies, the provision and uptake of HIV testing services in general and among key populations, and efforts being made to widen engagement with HIV testing and reduce late diagnosis.
External quality assessment of laboratory performance – European Antimicrobial Resistance Surveillance Network (EARS-Net), 2018
22 Nov 2019 - This report provides an analysis of the external quality assessment (EQA) performance with antimicrobial susceptibility testing (AST) of laboratories participating in the European Antimicrobial Resistance Surveillance Network in 2018. A total of 860 laboratories (1 – 114 per country) from 30 EU/EEA countries participated in the EQA exercise. Six bacterial strains were used: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Enterococcus faecium and Streptococcus pneumoniae.